NEW YORK – Protein sequencing firm Quantum-Si has regained compliance with Nasdaq listing requirements, according to a filing with the US Securities and Exchange Commission last week.
As of Dec. 4, the company's stock had closed above $1.00 per share for 10 consecutive business days, bringing it back into compliance with the Nasdaq's minimum bid price requirement.
At the beginning of November, Quantum-Si received notice from the Nasdaq that it no longer met the requirement for listing on the exchange as its stock had closed at or below $1.00 per share for 30 consecutive business days. It had 180 days to regain compliance.
On Nov. 20, the company's shares jumped following an investor day presentation in which it detailed plans for a new proteome-scale sequencing platform called Proteus, closing at $1.39 after closing at $.63 the day before. Quantum-Si has maintained a closing price of greater than $1.00 since then.